PS232. Expression of the Heat Shock Protein HSPB1 Is Associated With Impaired Smooth Muscle Relaxation  by Rizvi, Syed Z. et al.
JOURNAL OF VASCULAR SURGERY
June Supplement 201078S AbstractsObjectives: Cilostazol is known to be a selective inhib-
itor of phosphordiesterase 3 (PDE3) and is generally used
as a pharmacological tool in the patients with peripheral
arterial disease (PAD). Cilostazol has several beneficial
effects, however, little information is available about the
angiogenesis. In the present study, we investigated whether
cilostazol induces improvement of blood flow in the isch-
emic hindlimb of mouse, and if so, examined the mecha-
nisms of angiogenesis.
Methods: Wild-type (WT) mice were separated into
two groups. One is control group that was treated regular
food. The other is cilostazol group that was treated cilosta-
zol as food admixture at a concentration of 0.1%. Ischemic
hindlimb model of mice was made by ligation left femoral
artery and branched artery. Laser Doppler measurements of
blood flowwere compared between the control and cilosta-
zol group, on before and postoperative days 0,3,7 and 14.
The effect of NOS inhibitor (NG-nitro-L-arginine methyl
ester) on cilostazol group was also investigated using Laser
Doppler analysis. Capillary density in histological samples
of adductor muscle immunostained with an anti-CD31
monoclonal antibody was observed on postoperative day
14. The phosphorylation of endothelial nitric oxide syn-
thase (eNOS) was assessed by Western blot analysis on
postoperative day 5.Results: In cilostazol group, an angio-
genesis by laser Doppler measurements of blood flow
(p0.05) and capillary density in adductor muscle
(p0.05) in ischemic hindlimb model of mice were signif-
icantly enhanced compared to non-treated mice (control),
respectively. Cilostazol-induced angiogenesis were signifi-
cantly inhibited by treatment of NOS inhibitor. Western
blot analysis demonstrated that treatment with Cilostazol
induced the increasing in eNOS phosphorylation in isch-
emic tissue.
Conclusions: These results suggest that cilostazol
caused angiogenesis in ischemic hindlimb model of mouse.
This angiogenesis may be due to the enhancement of nitric
oxide production.
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Objectives: Chronic venous insufficiency (CVI) is an
enormous health burden, affecting 2.5 million patients
with advanced disease and leg ulceration per year with costs
in the United States alone exceeding $1 billion annually.
We developed a novel in-vitro cell culture model to exam-ine alterations in the TGF-1 pathway, previously shown to
be disrupted in human venous ulcers.
Methods: Commercially available healthy, adult der-
mal fibroblasts (early passage) were used to represent “nor-
mal fibroblasts” not yet subjected to the pathologic stretch
experienced in CVI. The healthy fibroblasts were incubated
on collagen coated plates, and a Flexercell® strain unit set
to continuous stretch at 21% above ATM with equibiaxial
elongation was used to subject these cells to a pathologic
stretch environment for 1, 5 and 7 days. Alterations in
TGF-1 secretion and TGF-1 Receptor (I and II) expres-
sion in response to mechanical stretch were detected by
fluorescence activated cell sorting analysis (flow cytometry)
and measured by % antibody expression and mean fluores-
cent intensity. Extracellular (secreted) TGF-1 was quan-
tified in media using enzyme linked immunosorbent assay
and fibroblast migratory capacity was measured using the
Boyden chamber transwell migration assay.
Results: TGF-1 secretion from dermal fibroblasts
subjected to 24 hours of stretch was 5-fold less compared to
their control (1169 vs 219 pg/mL, p  0.05). Transwell
migration was also reduced in stretched cells. A significant
reduction in TGF-1 Receptor I expression (70.4% vs
36.1%, p  0.04) following 5 days of mechanical stretch
was also demonstrated.
Conclusions:This model reliably induces reproducible
TGF-1 dysregulation in dermal fibroblasts. Our results
support the observation that pathological dermal stretch is
associated with and plays an integral role in the disruption
of the TGF-1 pathway present in CVI.
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Objectives: The small heat shock protein (HSP27 or
HSPB1) has been implicated in regulating vascular smooth
muscle tone. HSPB1 is phosphorylated by a stress activated
signaling cascade which includes p38 MAP kinase and
MAPKAP kinase II (MK2). The purpose of this investiga-
tion was to determine if HSPB1 expression correlated with
vascular responses in human saphenous vein (HSV).
Methods: Discarded segments of HSV after peripheral/
coronary revascularizations were tested in muscle bath.
Immunoblotting was performed to determine HSPB1
expression.
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coronary bypass had no functional viability (n  39).
HSPB1 expression and phosphorylation were inversely as-
sociated with relaxation in response to sodium nitroprus-
side (figure 1). Inhibiting HSPB1 phosphorylation by pre-
treatment with SB203580, a p38 MAPK inhibitor or a cell
permeant peptide inhibitor of MK2, MK2i, enhanced re-
laxation (p  0.05 figure 2). Rat aortic smooth muscle
contains low levels of HSPB1; when treated with recombi-
nant HSPB1 with a protein transduction domain allowing
cell entry (rPTDHSPB1) led to increased HSPB1 impair-
ing relaxation (figure 3).
Conclusions: Taken together, these studies support a
role for HSPB1 in impaired relaxation of smooth muscle.
Author Disclosures: C. M. Brophy: Nothing to disclose;
J. Cheung-Flynn: Nothing to disclose; K. M. Hocking:
Nothing to disclose; P. Komalavilas: Nothing to disclose;
E. Morley: Nothing to disclose; S. Z. Rizvi: Nothing to
disclose.
PS234.
A Mouse Model of Vascular Grafting
Chi-Nan Tseng, Einar Eriksson, Ulf Hedin. Department of
molecular medicine and surgery, Karolinska instiutet,
Stockholm, Sweden
Objectives: Grafting of surgically transplanted arteries
and veins to the arterial circulation is common in cardio-
vascular practice. Venous grafts degenerate rapidly follow-
ing implantation with intimal hyperplasia playing an impor-
tant role. In contrast, arterial grafts have excellent patency
rates in the long-term and might be superior to vein grafts.
Here we describe arterial and venous grafting to the mouse
aorta.
Methods: A model for implantation of vascular grafts
was established by transfer of the vena cava from donor
animals to the abdominal aorta in recipients. Arterial graft-
ing was performed by transfer of the abdominal aorta from
donor mouse to the same site in recipients. Histology,
scanning electron microscopy and confocal microscopy
were used to study development of intimal hyperplasia and
structural changes following transfer. Intravital microscopy
was used to study interactions between leukocytes and graft
endothelium.
Results: At different time points postop, scanning elec-
tron microscopy revealed that venous graft endothelium suf-
fers structural injurywhereas arterial grafts showno changes in
endothelial integrity. By cross transfer of grafts fromTie2GFP
mice that carry fluorescent endothelial cells intoWTmice and
subsequent confocal microscopy we determined that degen-
erated endothelium in venous grafts are of amixed originwith
most cells coming from the grafts but with contribution from
arterial endothelium and/or circulating endothelial progeni-
tor cells. Intimal hyperplasia was well developed at 28 days.
Intravital microscopy showed rolling and recruitment of leu-kocytes in vein grafts at 28 days and no such interactions were
observed in arterial grafts.
Conclusions: We’ve developed a stable and reproduc-
ible mousemodel of vascular grafting.We show endothelial
injury, intimal hyperplasia and inflammatory recruitment of
leukocytes in vein grafts but not in arterial grafts. This
animal model will be used in future experiments studying
the roles of inflammation in the formation of intimal hyper-
plasia.
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Objectives: Infections of indwelling medical devices
remain a source of morbidity and mortality. We have been
investigating the use of thin film nickel titanium (TFN) as a
novel material to cover stents for a wide array of vascular
applications, and have demonstrated that a super hydro-
philic surface treatment prevents platelet adhesion and de-
creases bacterial adhesion. The current study aimed to
show that biofilm producing bacteria will be unlikely to
form biofilm on super hydrophilic TFN (S-TFN) and that
any bacterial adhesion can be more effectively treated with
therapeutic doses of antibiotics compared to commercially
available endograft materials.
Methods: TFN was created using a sputter deposition
technique to a uniform thickness of 5 microns. TFN then
underwent surface treatment to create a hydrophilic layer.
Bacterial studies were conducted using Staphylococcus
Epidermidis strain 35984, a well characterized biofilm pro-
ducing species. 1cm2 samples of Dacron, ePTFE, Un-
treated TFN and S-TFN were placed in 10ml tryptic soy
broth, inoculated with 107 bacteria, and incubated at 37oC
for 24 hours. Samples were then treated with therapeutic
doses of rifampin/vancomycin for 24 hours. SEM images
were taken both before and after treatment.
Results: SEM imaging studies demonstrated consistently
decreased bacterial adhesion on S-TFN compared to all sam-
ples with significantly less biofilm deposition. Treatment with
antibiotics for 24 hours demonstrated near clearance of bac-
teria on S-TFN with all other samples having evidence of
persistent biofilm.
Conclusions: We demonstrate that the surface proper-
ties of S-TFN, namely its negatively charged, super hydro-
philic, and ultra smooth surface reduce the likelihood of
bacterial adhesion and significantly reduce biofilm deposi-
